Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approach.

about

Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approach.

Item

http://www.wikidata.org/entity/Q38056113

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Management of ventricular and ...... s a patient-specific approach.

@en

type

Item

label

Management of ventricular and ...... s a patient-specific approach.

@en

prefLabel

Management of ventricular and ...... s a patient-specific approach.

@en

P1476

Management of ventricular and ...... s a patient-specific approach.

@en

P2093

Akli Otmani

http://www.w3.org/2001/XMLSchema#string

Eloi Marijon

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Le Heuzey

http://www.w3.org/2001/XMLSchema#string

Thomas Lavergne

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Effect of dronedarone on cardiovascular events in atrial fibrillation

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

Increased mortality after dronedarone therapy for severe heart failure

Dronedarone in High-Risk Permanent Atrial Fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

A comparison of rate control and rhythm control in patients with atrial fibrillation.

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

P304

v125-v128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EUROPACE/EUS283

http://www.w3.org/2001/XMLSchema#string

P478

14 Suppl 5

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232740088

http://www.w3.org/2001/XMLSchema#string

P698

23104909

http://www.w3.org/2001/XMLSchema#string